Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Evidence for additive and synergistic action of mammalian enhancers during cell fate determination [BRD4-ChIP-seq, H3K4me1-ChIP-seq, TT-seq, RNA-seq]

ABSTRACT: Evidence for additive and synergistic action of mammalian enhancers during cell fate determination [BRD4-ChIP-seq, H3K4me1-ChIP-seq, TT-seq, RNA-seq]

PROVIDER: PRJNA630736 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11730070_1.fastq.gz	Fastqsanger.gz
	SRR11730070_2.fastq.gz	Fastqsanger.gz
	SRR11730071_1.fastq.gz	Fastqsanger.gz
	SRR11730071_2.fastq.gz	Fastqsanger.gz
	SRR11730072_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 112

Similar Datasets

H3K4me1 ChIP-seq in ALL-SIL

Project description:H3K4me1 ChIP-seq in ALL-SIL

| PRJNA434172 | ENA

H3K4me1 ChIP-seq analysis in Jurkat cells

Project description:H3K4me1 ChIP-seq analysis in Jurkat cells

| PRJNA489252 | ENA

Quantitative ChIP-MS analysis of proteins associated with H3K4me1- and H3K4me3-enriched mono-nucleosomes purified from crosslinked IMR-90 cells

Project description:Here we used ChIP-MS to quantitatively profile chromatin-associated proteins that are specifically associated with H3K4me1- and H3K4me3-modified nucleosomes in IMR-90 chromatin.

2023-12-10 | PXD042826 | Pride

H3K4me1 ChIP-seq of untreated HeLa S3 cells

Project description:H3K4me1 ChIP-seq of untreated HeLa S3 cells

| PRJEB31084 | ENA

ChIP-Seq of Histone H3K4me1 and H3K4me3 in human GIST48 cells

Project description:We previously mapped ETV1 using ChIP-Seq in GIST48 cells (GSE22441). Here, we map the enhancer landscape marked by histone H3K4me1 and the promoter landscape marked by histone H3K4me3 in GIST48 cells. Crosslink ChIP-Seq of H3K4me1 and H3K4me3 in GIST48 cells

2015-01-01 | E-GEOD-64609 | biostudies-arrayexpress

H3K4me1 ChIP-seq in murine pro-B cells

Project description:H3K4me1 binding in murine pre-B cells detected by ChIP-seq. For the ChIP-seq, input and immunoprecipitated DNA was given to the TSRI Next Generation Sequencing Core (the Scripps Research Institute, La Jolla, CA, US), where it was prepared for massively parallel sequencing on Illumina HiSeq2000.

2016-10-25 | E-GEOD-79054 | biostudies-arrayexpress

Valine-restricted diet regulates DNA methylation [H3K4me1 ChIP-Seq]

Project description:Valine-restricted diet regulates DNA methylation [H3K4me1 ChIP-Seq]

| PRJNA1148980 | ENA

Evidence for additive and synergistic action of mammalian enhancers during cell fate determination [BRD4-ChIP-seq, H3K4me1-ChIP-seq, TT-seq, RNA-seq]

Project description:Enhancer activity is known to drive cell differentiation and cell type determination, but it remains unclear how enhancers cooperate during these processes. Here we investigate enhancer cooperation during transdifferentiation of human B-cells to macrophages using enhancer RNA synthesis from accessible, H3K4-monomethylated chromatin regions as a proxy for enhancer activity. Most enhancers cooperate in an additive way to induce transcription of target genes. However, at ~130 loci, enhancers cooperate synergistically, changing activity of target genes exponentially over time. The latter genes are cell type-specific, indicating that enhancer synergy can drive differentiation and cell type determination. Pioneering factor occupancy, DNA accessibility profiling and eRNA synthesis reveal the temporal order of events that lead to enhancer synergy. Our results are consistent with a condensation model for transcription activation of cell type-specific genes that involves simultaneous contacts of multiple enhancers with their target promoter.

2021-04-07 | GSE149886 | GEO

RNA-seq and ChIP-seq H3K4me1 H3K4me2 H3K4me3 for Col-0

Project description:RNA-seq and ChIP-seq H3K4me1 H3K4me2 H3K4me3 for Col-0

| PRJNA1080258 | ENA

Identification of ChIP-seq and RIME grade antibodies for Estrogen Receptor alpha

Project description:Estrogen Receptor alpha (ERα) is a key driver of most breast cancers, and it is the target of endocrine therapies used in the clinic to treat women with ERα positive (ER+) breast cancer. The two methods ChIP-seq (chromatin immunoprecipitation coupled with deep sequencing) and RIME (Rapid Immunoprecipitation of Endogenous Proteins) have greatly improved our understanding of ERα function during breast cancer progression and in response to anti-estrogens. A critical component of both ChIP-seq and RIME protocols is the antibody that is used to pull down the bait protein. To date, most of the ChIP-seq and RIME experiments for the study of ERα have been performed using the sc-543 antibody from Santa Cruz Biotechnology. However, this antibody has been discontinued, thereby severely impacting the study of ERα in normal physiology as well as diseases such as breast cancer and ovarian cancer. Here, we compare the sc-543 antibody with other commercially available antibodies, and we show that 06-935 (EMD Millipore) and ab3575 (Abcam) antibodies can successfully replace the sc-543 antibody for ChIP-seq and RIME experiments.

2019-03-21 | PXD012930 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data